Acquisitions (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Combination [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Combination | The purchase price allocation for Inari is:
On May 7, 2026 we acquired Amplitude Vascular Systems, Inc. (AVS) for approximately $435 in cash and up to $400 in future milestone payments. AVS is developing a next-generation intravascular lithotripsy platform designed to treat complex peripheral arterial disease. We plan to integrate AVS into our Vascular business within MedSurg and Neurotechnology.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Finite-Lived Intangible Assets, Future Amortization Expense |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||